Abstract IA12: Developing combinatorial therapies for KRAS-driven cancers
Sign Up to like & getrecommendations! Published in 2023 at "Molecular Cancer Research"
DOI: 10.1158/1557-3125.ras23-ia12
Abstract: The RAS pathway is one of the most commonly deregulated pathways in human cancer. Approximately 30% of all tumors harbor activating mutations in either KRAS, NRAS or HRAS, and even more possess alterations in other… read more here.
Keywords: abstract ia12; combinatorial therapies; driven cancers; developing combinatorial ... See more keywords